Steve Harr, See Remarks at Juno Therapeutics, Inc. (JUNO), sold 5,000 shares at $45.00 ($225K) on 2016-03-04, disclosed to the SEC on 2016-03-04.
Open-market sale of $225k JUNO by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| JUNO | SELL | 2017-06-29 | $263K | — | Filing → |
| JUNO | SELL | 2016-06-13 | $2.6M | — | Filing → |
| JUNO | SELL | 2016-03-02 | $2.2M | — | Filing → |